Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10%
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Cancer, Early-Onset
Interventions: DRUG: Giredestrant|DRUG: Tamoxifen
Sponsor: MedSIR